Molecular Mechanisms of Adipose Organ Remodelling

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Tissues and Organs".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 4365

Special Issue Editors


E-Mail Website
Guest Editor
Obesity Center, Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy
Interests: diabetes; metabolic syndrome; nutrition; adipose organ; insulin resistance; metabolism; obesity; metabolic diseases; fat; metabolic endocrinology; breast; cancer; alveologenesis; pregnancy; lactation; postlactation
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Dipartimento di Scienze Biomediche e Sanità Pubblica, Facolta di Medicina e Chirurgia, Università Politecnica delle Marche, Via Tronto, 10, 60126 Torrette di Ancona, Italy
Interests: adipose organ; cancer; heart; neurodegenerative diseases; regenerative medicine

Special Issue Information

Dear Colleagues,

Adipose tissues are organized to form a dissectible structure called the adipose organ. White adipose tissue (WAT) is formed by unilocular spherical cells containing a lipid vacuole that occupies most of the cell volume. This cell secretes fatty acids required for the 24 hours activity of the heart and all other tissues. Furthermore, it also produces two hormones that induce nutritional behaviours (search for food and food intake) and hepatic glucogenesis. Brown adipose tissue (BAT) is formed by smaller cells rich in mitochondria with several small lipid vacuoles. BAT burns lipids in special mitochondria provided with a unique protein (UCP1) responsible for the final result of its physiology: thermogenesis. Thus, although both tissues are formed by cells fulfilling the definition of adipocytes because of their abundant cytoplasmic lipids, they have different anatomies and different physiologies, which raises the question of their eventual cooperation. Usually, different tissues contained in organs cooperate for a finalistic purpose. Cold is the physiologic stimulus for BAT, and chronic cold also induces a browning of WAT, with the increment of thermogenesis. On the other hand, during a normal diet, WAT takes care of the metabolic needs of the organism, but in the case of a chronic positive energy balance, the organism exerts all of its ability to store precious calories, considering that a fasting period is not predictable; thus, in this particular condition, BAT convert into WAT to increase the body’s storing capacity. This theory offers an explanation as to why WAT and BAT are contained in the same organ, but implies a novel basic property for cells: the ability for a physiologic reversible gene reprogramming with a change of phenotype. We observed another striking example of cell conversion in the adipose organ during pregnancy and lactation. The alveolar part of mammary glands develops only in this period, in which the adipose component of the organ gradually disappears. Electron microscopy, lineage tracing, and explants data suggest that mammary alveolar cells are derived, at least in part, from the direct conversion of adipocytes.

Thus, the adipose organ is provided with a high level of plasticity, and a deeper knowledge of the molecular mechanisms responsible for its plasticity ,main purpose of this special issue, could open novel avenues for drug targets to treat obesity and related disorders, including breast cancer.

Prof. Dr. Saverio Cinti
Dr. Laura Graciotti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adipose organ
  • white adipose tissue
  • brown adipose tissue
  • breast
  • alveologenesis
  • pregnancy
  • lactation
  • post-lactation
  • transdifferentiation
  • conversion
  • plasticity
  • remodelling
  • molecular mechanisms
  • obesity
  • diabetes
  • fat
  • endocrinology

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

14 pages, 2868 KiB  
Article
Effects of Fatty Acid Metabolites on Adipocytes Britening: Role of Thromboxane A2
by Cécilia Colson, Pierre-Louis Batrow, Sebastian Dieckmann, Laura Contu, Christian H. Roux, Laurence Balas, Claire Vigor, Baptiste Fourmaux, Nadine Gautier, Nathalie Rochet, Nathalie Bernoud-Hubac, Thierry Durand, Dominique Langin, Martin Klingenspor and Ez-Zoubir Amri
Cells 2023, 12(3), 446; https://doi.org/10.3390/cells12030446 - 30 Jan 2023
Cited by 3 | Viewed by 1882
Abstract
Obesity is a complex disease highly related to diet and lifestyle and is associated with low amount of thermogenic adipocytes. Therapeutics that regulate brown adipocyte recruitment and activity represent interesting strategies to fight overweight and associated comorbidities. Recent studies suggest a role for [...] Read more.
Obesity is a complex disease highly related to diet and lifestyle and is associated with low amount of thermogenic adipocytes. Therapeutics that regulate brown adipocyte recruitment and activity represent interesting strategies to fight overweight and associated comorbidities. Recent studies suggest a role for several fatty acids and their metabolites, called lipokines, in the control of thermogenesis. The purpose of this work was to analyze the role of several lipokines in the control of brown/brite adipocyte formation. We used a validated human adipocyte model, human multipotent adipose-derived stem cell model (hMADS). In the absence of rosiglitazone, hMADS cells differentiate into white adipocytes, but convert into brite adipocytes upon rosiglitazone or prostacyclin 2 (PGI2) treatment. Gene expression was quantified using RT-qPCR and protein levels were assessed by Western blotting. We show here that lipokines such as 12,13-diHOME, 12-HEPE, 15dPGJ2 and 15dPGJ3 were not able to induce browning of white hMADS adipocytes. However, both fatty acid esters of hydroxy fatty acids (FAHFAs), 9-PAHPA and 9-PAHSA potentiated brown key marker UCP1 mRNA levels. Interestingly, CTA2, the stable analog of thromboxane A2 (TXA2), but not its inactive metabolite TXB2, inhibited the rosiglitazone and PGI2-induced browning of hMADS adipocytes. These results pinpoint TXA2 as a lipokine inhibiting brown adipocyte formation that is antagonized by PGI2. Our data open new horizons in the development of potential therapies based on the control of thromboxane A2/prostacyclin balance to combat obesity and associated metabolic disorders. Full article
(This article belongs to the Special Issue Molecular Mechanisms of Adipose Organ Remodelling)
Show Figures

Figure 1

Review

Jump to: Research, Other

39 pages, 5797 KiB  
Review
Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ Dysfunction
by Carla Iacobini, Martina Vitale, Jonida Haxhi, Stefano Menini and Giuseppe Pugliese
Cells 2024, 13(9), 763; https://doi.org/10.3390/cells13090763 - 30 Apr 2024
Viewed by 561
Abstract
The adipose organ adapts and responds to internal and environmental stimuli by remodeling both its cellular and extracellular components. Under conditions of energy surplus, the subcutaneous white adipose tissue (WAT) is capable of expanding through the enlargement of existing adipocytes (hypertrophy), followed by [...] Read more.
The adipose organ adapts and responds to internal and environmental stimuli by remodeling both its cellular and extracellular components. Under conditions of energy surplus, the subcutaneous white adipose tissue (WAT) is capable of expanding through the enlargement of existing adipocytes (hypertrophy), followed by de novo adipogenesis (hyperplasia), which is impaired in hypertrophic obesity. However, an impaired hyperplastic response may result from various defects in adipogenesis, leading to different WAT features and metabolic consequences, as discussed here by reviewing the results of the studies in animal models with either overexpression or knockdown of the main molecular regulators of the two steps of the adipogenesis process. Moreover, impaired WAT remodeling with aging has been associated with various age-related conditions and reduced lifespan expectancy. Here, we delve into the latest advancements in comprehending the molecular and cellular processes underlying age-related changes in WAT function, their involvement in common aging pathologies, and their potential as therapeutic targets to influence both the health of elderly people and longevity. Overall, this review aims to encourage research on the mechanisms of WAT maladaptation common to conditions of both excessive and insufficient fat tissue. The goal is to devise adipocyte-targeted therapies that are effective against both obesity- and age-related disorders. Full article
(This article belongs to the Special Issue Molecular Mechanisms of Adipose Organ Remodelling)
Show Figures

Figure 1

13 pages, 4832 KiB  
Review
Bone Marrow Adipose Tissue
by Elena Marinelli Busilacchi, Erika Morsia and Antonella Poloni
Cells 2024, 13(9), 724; https://doi.org/10.3390/cells13090724 - 23 Apr 2024
Viewed by 640
Abstract
Bone marrow (BM) acts as a dynamic organ within the bone cavity, responsible for hematopoiesis, skeletal remodeling, and immune system control. Bone marrow adipose tissue (BMAT) was long simply considered a filler of space, but now it is known that it instead constitutes [...] Read more.
Bone marrow (BM) acts as a dynamic organ within the bone cavity, responsible for hematopoiesis, skeletal remodeling, and immune system control. Bone marrow adipose tissue (BMAT) was long simply considered a filler of space, but now it is known that it instead constitutes an essential element of the BM microenvironment that participates in homeostasis, influences bone health and bone remodeling, alters hematopoietic stem cell functions, contributes to the commitment of mesenchymal stem cells, provides effects to immune homeostasis and defense against infections, and participates in energy metabolism and inflammation. BMAT has emerged as a significant contributor to the development and progression of various diseases, shedding light on its complex relationship with health. Notably, BMAT has been implicated in metabolic disorders, hematological malignancies, and skeletal conditions. BMAT has been shown to support the proliferation of tumor cells in acute myeloid leukemia and niche adipocytes have been found to protect cancer cells against chemotherapy, contributing to treatment resistance. Moreover, BMAT’s impact on bone density and remodeling can lead to conditions like osteoporosis, where high levels of BMAT are inversely correlated with bone mineral density, increasing the risk of fractures. BMAT has also been associated with diabetes, obesity, and anorexia nervosa, with varying effects on individuals depending on their weight and health status. Understanding the interaction between adipocytes and different diseases may lead to new therapeutic strategies. Full article
(This article belongs to the Special Issue Molecular Mechanisms of Adipose Organ Remodelling)
Show Figures

Figure 1

Other

Jump to: Research, Review

12 pages, 1413 KiB  
Commentary
Overactivation of the Endocannabinoid System in Adolescence Disrupts Adult Adipose Organ Function in Mice
by Kwang-Mook Jung, Lin Lin and Daniele Piomelli
Cells 2024, 13(5), 461; https://doi.org/10.3390/cells13050461 - 6 Mar 2024
Viewed by 763
Abstract
Cannabis use stimulates calorie intake, but epidemiological studies show that people who regularly use it are leaner than those who don’t. Two explanations have been proposed for this paradoxical finding. One posits that Δ9-tetrahydrocannabinol (THC) in cannabis desensitizes adipose CB1 cannabinoid [...] Read more.
Cannabis use stimulates calorie intake, but epidemiological studies show that people who regularly use it are leaner than those who don’t. Two explanations have been proposed for this paradoxical finding. One posits that Δ9-tetrahydrocannabinol (THC) in cannabis desensitizes adipose CB1 cannabinoid receptors, stopping their stimulating effects on lipogenesis and adipogenesis. Another explanation is that THC exposure in adolescence, when habitual cannabis use typically starts, produces lasting changes in the developing adipose organ, which impacts adult systemic energy use. Here, we consider these possibilities in the light of a study which showed that daily THC administration in adolescent mice produces an adult metabolic phenotype characterized by reduced fat mass, partial resistance to obesity and dyslipidemia, and impaired thermogenesis and lipolysis. The phenotype, whose development requires activation of CB1 receptors in differentiated adipocytes, is associated with overexpression of myocyte proteins in the adipose organ with unchanged CB1 expression. We propose that adolescent exposure to THC causes lasting adipocyte dysfunction and the consequent emergence of a metabolic state that only superficially resembles healthy leanness. A corollary of this hypothesis, which should be addressed in future studies, is that CB1 receptors and their endocannabinoid ligands may contribute to the maintenance of adipocyte differentiation during adolescence. Full article
(This article belongs to the Special Issue Molecular Mechanisms of Adipose Organ Remodelling)
Show Figures

Graphical abstract

Back to TopTop